1. Home
  2. EXAS vs LNW Comparison

EXAS vs LNW Comparison

Compare EXAS & LNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • LNW
  • Stock Information
  • Founded
  • EXAS 1995
  • LNW 1984
  • Country
  • EXAS United States
  • LNW United States
  • Employees
  • EXAS N/A
  • LNW N/A
  • Industry
  • EXAS Medical Specialities
  • LNW EDP Services
  • Sector
  • EXAS Health Care
  • LNW Technology
  • Exchange
  • EXAS Nasdaq
  • LNW Nasdaq
  • Market Cap
  • EXAS 10.1B
  • LNW 8.5B
  • IPO Year
  • EXAS N/A
  • LNW N/A
  • Fundamental
  • Price
  • EXAS $48.49
  • LNW $97.80
  • Analyst Decision
  • EXAS Strong Buy
  • LNW Buy
  • Analyst Count
  • EXAS 20
  • LNW 12
  • Target Price
  • EXAS $70.26
  • LNW $108.42
  • AVG Volume (30 Days)
  • EXAS 2.6M
  • LNW 576.1K
  • Earning Date
  • EXAS 08-06-2025
  • LNW 08-06-2025
  • Dividend Yield
  • EXAS N/A
  • LNW N/A
  • EPS Growth
  • EXAS N/A
  • LNW 56.05
  • EPS
  • EXAS N/A
  • LNW 3.74
  • Revenue
  • EXAS $2,828,128,000.00
  • LNW $3,206,000,000.00
  • Revenue This Year
  • EXAS $14.61
  • LNW $8.59
  • Revenue Next Year
  • EXAS $12.65
  • LNW $7.48
  • P/E Ratio
  • EXAS N/A
  • LNW $26.15
  • Revenue Growth
  • EXAS 11.57
  • LNW 7.30
  • 52 Week Low
  • EXAS $39.97
  • LNW $75.46
  • 52 Week High
  • EXAS $72.83
  • LNW $115.00
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 38.76
  • LNW 56.23
  • Support Level
  • EXAS $48.15
  • LNW $96.26
  • Resistance Level
  • EXAS $53.95
  • LNW $100.38
  • Average True Range (ATR)
  • EXAS 2.10
  • LNW 2.32
  • MACD
  • EXAS -0.51
  • LNW -0.46
  • Stochastic Oscillator
  • EXAS 4.39
  • LNW 30.13

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About LNW Light & Wonder Inc.

Light & Wonder is principally an electronic gaming machine manufacturer, selling machines to pubs, clubs, and casinos. The firm is licensed in most jurisdictions allowing gambling globally. Light & Wonder is one of the three largest players in the space along with International Game Technology and Aristocrat Leisure. SciPlay, about one fourth of revenue, develops and distributes casual mobile games, principally in the social casino niche. The more nascent iGaming business sits between these two businesses, providing digital content and capabilities to real-money gaming providers.

Share on Social Networks: